Ataluren Update- Phase 3 trial planned for 2014

PTC had their first investor conference yesterday, here is a brief summary: - Second phase 3 Ataluren study planned to start in the first half of 2014 with CF nonsense mutations - Plan to apply to the EMA (Europe) this year - Potential for combination with Vertex's Kalydeco discussed during investor conference, PTC looking at ways to evaluate this concept More info here: http://sixtyfiverosesblog.wordpress....aluren-update/
Source: Cystic Fibrosis CFTR Modulation and Gene Therapy Forum - Category: Respiratory Medicine Authors: Tags: CFTR Modulation and Gene Therapy Talk Source Type: forums